extremists, but adds: 'It would not be sensible to try to seek a separate bill which, because of pressures of parliamentary time, could not be taken this year. ' Britain's pharmaceutical giants also responded to the growing threat from animal rights activists last month by launching a £4 million research fund to pay for animal experiments in universities. The three multinational drug companies with the largest research operations in the UK, GlaxoSmithKline, AstraZeneca and Pfizer, said they would back fellowships and pay for laboratory equipment to help universities continue animal testing in the face of increasing hostility from campaigners.
The British government is bolstering legislation to curb the activity of animal rights protesters who threaten researchers as pharmaceutical companies pledge funds to support animal testing in universities in the face of fears that their crucial supply of graduate and postgraduate recruits is under threat.
A hastily assembled programme of legislative reform was released in response to the success of direct action in stopping work on a new laboratory for Oxford University and forcing the main contractor, Montpellier, to abandon the project last month.
The government responded with a 20-page document, with a foreword signed jointly by the prime minister, Tony Blair, and the home secretary, David Blunkett, defending the use of animals in research, which outlines attempts to develop medical alternatives and the need to concentrate on sharpening the existing array of law and order tools to defeat the extremists.
Three new offences are proposed to give the police power 'to tackle protests outside homes more effectively' and prevent the harassment of employees of companies involved in the pharmaceutical industry.
Officers Concerns about the power of extremists to disrupt research escalated last month when the main construction group pulled out of a contract to build a new animal research centre for Oxford University, after its shareholders received threatening letters. Cambridge dropped plans for a primate research centre south of the city in January.
The new fund was welcomed by the science minister, Lord Sainsbury. It will be administered by the British Pharmacological Association, which will use the money to give grants to research students, and support fellowships.
"In terms of new medicine discovery, I don't there is a single drug that hasn't at some point been dependent on the use of animal testing," said a spokesperson for the association. More animal experiments are carried out in Britain's universities than in industry -40 per cent of the total, compared to 37 per cent in the private sector.
The pharmaceutical companies, which already face attacks from animal extremists, are concerned that they could also be hit by a lack of trained scientists graduating from universities. "Being able to do this kind of research is key to our ability to deliver the best care to the patient," says Gill Samuels, executive director of science for Pfizer in Europe.
Drug companies are obliged by the government to test the safety of new products on animals before trying them out on human patients, but several have warned that the growing prevalence of animal rights activism could force them to move their research operations overseas. Few firms want to give details of attacks on their staff, but they list visits to the home addresses of employees, intimidating letters and 'telephone bombardment' as some of the tactics used by campaigners.
Spurred by strong lobbying from the drug industry, the government announced its new legal protection for scientists and other workers who have faced intimidation from groups such as Stop Huntingdon Animal Cruelty. "These people are committing crimes and they should be dealt with harshly," the home secretary David Blunkett said.
Scientists responded with guarded enthusiasm to the plans to tackle animal extremism. While the measures were welcomed, some pointed to gaps, such as protection of university science labs.
"This is the strongest statement to date, the most comprehensive strategy they have made," says Mark Matfield, executive director of the Research Defence Society, a group that lobbies on behalf of scientists who use animals in their research. "They've never put their vision on the lines as clearly and firmly as this."
But others are worried that any new powers may be not enough. The Association of Medical Research Charities, whose members spend £600 million a year on research in the UK, wrote to the Home Office last month to complain that ministers seemed to be focusing on protecting industry while ignoring academic researchers and the public funders of research. Diana Garnham, chief executive of the AMRC, said: "We know universities are on the front line, but there has been little talk about how university research institutes will be protected. The concern is that universities and charities will become soft targets for extremists.'
Universities UK, the vicechancellors' group, voiced similar concerns. A spokesperson said: "We hope that universities, other publicly funded research environments and charity institutes will not be forgotten and that attention will be paid to the wider group of individuals engaged in animal research."
There is scepticism about how far any changes to the law will be effective in tackling the issue of animal activism. Evan Harris, member of parliament for Oxford West said: "I'm not convinced that they will come up with anything very much." He has lobbied the government to underwrite security costs at universities and to pay the extra insurance of contractors who undertake controversial projects.
Lord Winston, professor of obstetrics and gynaecology at Imperial College London warned: "It is difficult to see what any government can do that will be truly effective -whether it is industry or private researchers or academic establishments that are being targeted."
The government has also become embroiled in an issue of prominent animal activists from the US holding positions sufficiently extreme to justify refusal to enter the country. The Home Office has written to a number of US campaigners, warning them that they may not be allowed into the UK if they are deemed to have made statements inciting violence in the UK. There is no appeal against exclusion, although campaigners in the UK can seek judicial reviews of Home Office decisions.
Among those written to was Jerry Vlasak, a California-based surgeon and advisor to the group leading the campaign to halt the construction of the Oxford laboratory. "I have every intention to take legal advice if they do ban me," he said.
